Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Liver Diseases

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 39 articles:
HTML format



Single Articles


    May 2025
  1. PAPARGYRIOU A, Reichert M
    The Biology in the Pattern: Metastatic Organotropism and Clinical Outcome Depend on DNA Damage Response and Immune Interactions in Pancreatic Cancer.
    Cancer Res. 2025;85:1571-1573.
    PubMed     Abstract available


    March 2025
  2. LEE TKW, Ma S
    PROX1: a key regulator of hepatocyte identity and tumorigenesis.
    Cancer Res. 2025 Mar 31. doi: 10.1158/0008-5472.CAN-25-1377.
    PubMed     Abstract available


  3. CHANG Y, Wang N, Li S, Zhang J, et al
    SLC3A2-Mediated Lysine Uptake by Cancer Cells Restricts T cell Activity in Hepatocellular Carcinoma.
    Cancer Res. 2025 Mar 24. doi: 10.1158/0008-5472.CAN-24-3180.
    PubMed     Abstract available


  4. WANG M, Zou F, Wang S, Yang Y, et al
    CRTC2 Forms Co-condensates with YTHDF2 that Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance.
    Cancer Res. 2025 Mar 4. doi: 10.1158/0008-5472.CAN-24-3196.
    PubMed     Abstract available


    January 2025
  5. CHEN R, Ma C, Qian H, Xie X, et al
    Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression.
    Cancer Res. 2025 Jan 24. doi: 10.1158/0008-5472.CAN-24-2097.
    PubMed     Abstract available


  6. XIE P, Guo L, Yu Q, Zhao Y, et al
    ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis.
    Cancer Res. 2025;85:299-313.
    PubMed     Abstract available


  7. LUO YW, Fang Y, Zeng HX, Ji YC, et al
    HIF1alpha Counteracts TGFbeta1-Driven TSP1 Expression in Endothelial Cells to Stimulate Angiogenesis in the Hypoxic Tumor Microenvironment.
    Cancer Res. 2025;85:69-83.
    PubMed     Abstract available


    December 2024
  8. XUE S, Chen X, Qiu G, Liao H, et al
    CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis.
    Cancer Res. 2024 Dec 18. doi: 10.1158/0008-5472.CAN-24-0147.
    PubMed     Abstract available


  9. TURNHAM RE, Pitea A, Jang GM, Xu Z, et al
    HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma.
    Cancer Res. 2024 Dec 9. doi: 10.1158/0008-5472.CAN-24-0456.
    PubMed     Abstract available


  10. YANG Y, Luo J, Wang Z, Liu K, et al
    Energy Stress-induced CircEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma.
    Cancer Res. 2024 Dec 5. doi: 10.1158/0008-5472.CAN-24-1630.
    PubMed     Abstract available


    November 2024
  11. ZHANG Q, Zhang Y, Fu C, He X, et al
    CSTF2 Supports Hypoxia Tolerance in Hepatocellular Carcinoma by Enabling m6A Modification Evasion of PGK1 to Enhance Glycolysis.
    Cancer Res. 2024 Nov 8. doi: 10.1158/0008-5472.CAN-24-2283.
    PubMed     Abstract available


    October 2024
  12. CUI Y, Chang Y, Ma X, Sun M, et al
    Ephrin A1 Stimulates CCL2 Secretion to Facilitate Pre-metastatic Niche Formation and Promote Gastric Cancer Liver Metastasis.
    Cancer Res. 2024 Oct 16. doi: 10.1158/0008-5472.CAN-24-1254.
    PubMed     Abstract available


    September 2024
  13. CONNER SJ, Borges HB, Guarin JR, Gerton TJ, et al
    Obesity Induces Temporally Regulated Alterations in the Extracellular Matrix That Drive Breast Tumor Invasion and Metastasis.
    Cancer Res. 2024;84:2761-2775.
    PubMed     Abstract available


  14. SHU Y, Jin X, Ji M, Zhang Z, et al
    Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis.
    Cancer Res. 2024;84:2836-2855.
    PubMed     Abstract available


  15. HOU PP, Zheng CM, Wu SH, Liu XX, et al
    Extracellular Vesicle-Packaged ACSL4 Induces Hepatocyte Senescence to Promote Hepatocellular Carcinoma Progression.
    Cancer Res. 2024 Sep 3. doi: 10.1158/0008-5472.CAN-24-0832.
    PubMed     Abstract available


    August 2024
  16. ZHANG S, Deshpande A, Verma BK, Wang H, et al
    Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery.
    Cancer Res. 2024;84:2734-2748.
    PubMed     Abstract available


    July 2024
  17. LIAO S, Deng J, Deng M, Chen C, et al
    AFDN deficiency promotes liver tropism of metastatic colorectal cancer.
    Cancer Res. 2024 Jul 24. doi: 10.1158/0008-5472.CAN-23-3140.
    PubMed     Abstract available


    June 2024
  18. SHIRANI M, Levin S, Shebl B, Requena D, et al
    Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1.
    Cancer Res. 2024 Jun 18. doi: 10.1158/0008-5472.CAN-23-4110.
    PubMed     Abstract available


  19. LI L, Xie D, Yu S, Ma M, et al
    WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma.
    Cancer Res. 2024 Jun 17. doi: 10.1158/0008-5472.CAN-23-1167.
    PubMed     Abstract available


    May 2024
  20. RETTIG AR, Ganesh K
    Cancer Cells Hijack Physiologic Metabolic Signals to Seed Liver Metastasis.
    Cancer Res. 2024;84:1548-1549.
    PubMed     Abstract available


  21. HE W, Wang M, Zhang X, Wang Y, et al
    Estrogen induces LCAT to maintain cholesterol homeostasis and suppress hepatocellular carcinoma development.
    Cancer Res. 2024 May 8. doi: 10.1158/0008-5472.CAN-23-3966.
    PubMed     Abstract available


  22. ZHANG R, Li S, Schippers K, Li Y, et al
    Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate beta-Catenin Signaling.
    Cancer Res. 2024;84:1443-1459.
    PubMed     Abstract available


    April 2024
  23. YANG S, Zhang D, Sun Q, Nie H, et al
    Single-Cell and Spatial Transcriptome Profiling Identifies the Transcription Factor BHLHE40 as a Driver of EMT in Metastatic Colorectal Cancer.
    Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-23-3264.
    PubMed     Abstract available


    March 2024
  24. HUANG J, Tsang WY, Fang XN, Zhang Y, et al
    FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma.
    Cancer Res. 2024;84:855-871.
    PubMed     Abstract available


  25. WENG J, Wang Z, Hu Z, Xu W, et al
    Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy.
    Cancer Res. 2024 Mar 14. doi: 10.1158/0008-5472.CAN-23-3106.
    PubMed     Abstract available


  26. LIAO H, Chen X, Wang H, Lin Y, et al
    Whole-genome DNA methylation profiling of intrahepatic cholangiocarcinoma reveals prognostic subtypes with distinct biological drivers.
    Cancer Res. 2024 Mar 12. doi: 10.1158/0008-5472.CAN-23-3298.
    PubMed     Abstract available


  27. WAN S, He QY, Yang Y, Liu F, et al
    SPARC stabilizes ApoE to induce cholesterol-dependent invasion and sorafenib resistance in hepatocellular carcinoma.
    Cancer Res. 2024 Mar 12. doi: 10.1158/0008-5472.CAN-23-2889.
    PubMed     Abstract available


    February 2024
  28. WANG Y, Cheng C, Lu Y, Lian Z, et al
    beta-catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma.
    Cancer Res. 2024 Feb 28. doi: 10.1158/0008-5472.CAN-23-0673.
    PubMed     Abstract available


  29. SONG M, Zhang C, Cheng S, Ouyang D, et al
    DNA of neutrophil extracellular traps binds TMCO6 to impair CD8+ T-cell immunity in hepatocellular carcinoma.
    Cancer Res. 2024 Feb 21. doi: 10.1158/0008-5472.CAN-23-2986.
    PubMed     Abstract available


  30. LIU X, Wang X, Yang Q, Luo L, et al
    Th17 cells secrete TWEAK to trigger epithelial-mesenchymal transition and promote colorectal cancer liver metastasis.
    Cancer Res. 2024 Feb 9. doi: 10.1158/0008-5472.CAN-23-2123.
    PubMed     Abstract available


    January 2024
  31. ZHANG X, Su T, Wu Y, Cai Y, et al
    N6-methyladenosine reader YTHDF1 promotes stemness and therapeutic resistance in hepatocellular carcinoma by enhancing NOTCH1 expression.
    Cancer Res. 2024 Jan 19. doi: 10.1158/0008-5472.CAN-23-1916.
    PubMed     Abstract available


  32. MU M, Huang CX, Qu C, Li PL, et al
    Targeting ferroptosis-elicited inflammation suppresses hepatocellular carcinoma metastasis and enhances sorafenib efficacy.
    Cancer Res. 2024 Jan 17. doi: 10.1158/0008-5472.CAN-23-1796.
    PubMed     Abstract available


    December 2023
  33. DATTA J, Kutay H, Nasser MW, Nuovo GJ, et al
    Retraction: Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular Carcinogenesis.
    Cancer Res. 2023;83:4181.
    PubMed    


  34. MAJUMDER S, Roy S, Kaffenberger T, Wang B, et al
    Retraction: Loss of Metallothionein Predisposes Mice to Diethylnitrosamine-Induced Hepatocarcinogenesis by Activating NF-kappaB Target Genes.
    Cancer Res. 2023;83:4179.
    PubMed    


    November 2023
  35. ZHUANG Q, Dai Z, Xu X, Bai S, et al
    RNA methyltransferase FTSJ3 regulates the type I interferon pathway to promote hepatocellular carcinoma immune evasion.
    Cancer Res. 2023 Nov 14. doi: 10.1158/0008-5472.CAN-23-2049.
    PubMed     Abstract available


  36. CHEN Z, Zhang G, Ren X, Yao Z, et al
    Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer.
    Cancer Res. 2023;83:3544-3561.
    PubMed     Abstract available


    September 2023
  37. SU T, Zhang N, Wang T, Zeng J, et al
    Super enhancer-regulated lncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis.
    Cancer Res. 2023 Sep 26. doi: 10.1158/0008-5472.CAN-23-0544.
    PubMed     Abstract available


  38. HUNG MH, Wang XW
    Targeting WNT/beta-catenin via modulating EZH2 function - a new chapter in the treatment of beta-catenin mutant hepatocellular carcinoma?
    Cancer Res. 2023 Sep 25. doi: 10.1158/0008-5472.CAN-23-2921.
    PubMed     Abstract available


    August 2023
  39. ZHENG Y, Zhou R, Cai J, Yang N, et al
    Matrix stiffness triggers lipid metabolic crosstalk between tumor and stromal cells to mediate bevacizumab resistance in colorectal cancer liver metastases.
    Cancer Res. 2023 Aug 23:CAN-23-0025. doi: 10.1158/0008-5472.CAN-23-0025.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.